Emerging neuroprotective interventions in periventricular leukomalacia - A systematic review of preclinical studies

References

• Blencowe H, Cousens S, Oestergaard MZ, et al. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet. 2012;379(9832):2162–2172. DOI:https://doi.org/10.1016/S0140-6736(12)60820-4.
   PubMed Web of Science ®Google Scholar
• Patel RM, Kandefer S, Walsh MC, et al. Causes and timing of death in extremely premature infants from 2000 through 2011. N Engl J Med. 2015;372(4):331–340. DOI:https://doi.org/10.1056/NEJMoa1403489.
   PubMed Web of Science ®Google Scholar
• Stoll BJ, Hansen NI, Bell EF, et al. Trends in care practices, morbidity, and mortality of extremely preterm neonates, 1993-2012. JAMA. 2015;314(10):1039–1051. DOI:https://doi.org/10.1001/jama.2015.102441.
   PubMed Web of Science ®Google Scholar
• Nakanishi H, Suenaga H, Uchiyama A, et al. Neonatal research network, Japan. Trends in the neurodevelopmental outcomes among preterm infants from 2003-2012: a retrospective cohort study in Japan. J Perinatol. 2018;38(7):917–928. DOI:https://doi.org/10.1038/s41372-018-0061-7.
   PubMed Web of Science ®Google Scholar
• Wang LW, Lin YC, Wang ST, Huang, CC . Taiwan premature infant follow-up network, tainan premature infant follow-up team and the participating hospitals. Trends in survival, neonatal morbidity and neurodevelopmental outcome of very preterm infants in Tainan, Southern Taiwan. J Formos Med Assoc. 2021;120(6): 1314–1323. doi:https://doi.org/10.1016/j.jfma.2020.12.025.
   PubMedGoogle Scholar
• Adams-Chapman I, Heyne RJ, and DeMauro SB, et al. Follow-Up Study of the Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Neurodevelopmental impairment among extremely preterm infants in the neonatal research Network. Pediatrics. 2018;141(5):e20173091. doi:https://doi.org/10.1542/peds.2017-3091.
   PubMedGoogle Scholar
• Pascal A, Govaert P, Oostra A, et al. Neurodevelopmental outcome in very preterm and very-low-birthweight infants born over the past decade: a meta-analytic review. Dev Med Child Neurol. 2018;60(4):342–355. DOI:https://doi.org/10.1111/dmcn.13675.
   PubMed Web of Science ®Google Scholar
• Kuban KCK, Allred EN, O’Shea TM, et al. Cranial ultrasound lesions in the NICU predict cerebral palsy at age 2 years in children born at extremely low gestational age. J Child Neurol. 2009;24(1):63–72. DOI:https://doi.org/10.1177/0883073808321048.
   PubMed Web of Science ®Google Scholar
• Kinney HC, Volpe JJ. Encephalopathy of prematurity: neuropathology. In: Volpe JJ, editor. Volpe’s neurology of the newborn. 6th ed. Philadelphia: Elsevier; 2018. p. 389–404.
   Google Scholar
• Jensen FE. Role of glutamate receptors in periventricular leukomalacia. J Child Neurol. 2005;20(12):950–959.
   PubMed Web of Science ®Google Scholar
• Zaghloul N, Ahmed M. Pathophysiology of periventricular leukomalacia: what we learned from animal models. Neural Regen Res. 2017;12(11):1795–1796.
   PubMed Web of Science ®Google Scholar
• Sotiriadis A, Tsiami A, Papatheodorou S, et al. Neurodevelopmental outcome after a single course of antenatal steroids in children born preterm: a systematic review and meta-analysis. Obstet Gynecol. 2015;125(6):1385–1396. DOI:https://doi.org/10.1097/AOG.0000000000000748.
   PubMed Web of Science ®Google Scholar
• Chawla S, Natarajan G, Shankaran S, et al. Association of neurodevelopmental outcomes and neonatal morbidities of extremely premature infants with differential exposure to antenatal steroids. JAMA Pediatr. 2016;170(12):1164–1172. DOI:https://doi.org/10.1001/jamapediatrics.2016.1936.
   PubMed Web of Science ®Google Scholar
• Zeng X, Xue Y, Tian Q, et al. Effects and safety of magnesium sulfate on neuroprotection: a meta-analysis based on PRISMA guidelines. Medicine (Baltimore). 2016;95(1):e2451. DOI:https://doi.org/10.1097/MD.0000000000002451.
   PubMed Web of Science ®Google Scholar
• Crowther CA, Middleton PF, Voysey M, et al. Assessing the neuroprotective benefits for babies of antenatal magnesium sulphate: an individual participant data meta-analysis. PLoS Med. 2017;14(10):e1002398. DOI:https://doi.org/10.1371/journal.pmed.1002398.
   PubMed Web of Science ®Google Scholar
• Rabe H, Gyte GM, Díaz-Rossello JL, et al. Effect of timing of umbilical cord clamping and other strategies to influence placental transfusion at preterm birth on maternal and infant outcomes. Cochrane Database Syst Rev. 2019; 9. CD003248 https://doi.org/10.1002/14651858.CD003248.pub4
   Google Scholar
• Schmidt B, Roberts RS, Davis P, et al. Long-term effects of caffeine therapy for apnea of prematurity. N Engl J Med. 2007;357(19):1893–1902. DOI:https://doi.org/10.1056/NEJMoa073679.
   PubMed Web of Science ®Google Scholar
• Mürner-Lavanchy IM, Doyle LW, and Schmidt B , et al. Caffeine for Apnea of Prematurity (CAP) Trial Group. Neurobehavioral outcomes 11 years after neonatal caffeine therapy for apnea of prematurity. Pediatrics. 2018;141(5):e20174047. doi:https://doi.org/10.1542/peds.2017-4047.
   PubMed Web of Science ®Google Scholar
• Chan SHT, Johnson MJ, Leaf AA, et al. Nutrition and neurodevelopmental outcomes in preterm infants: a systematic review. Acta Paediatr. 2016;105(6):587–599. DOI:https://doi.org/10.1111/apa.13344.
   PubMed Web of Science ®Google Scholar
• Ouzzani M, Hammady H, Fedorowicz Z, et al. Rayyan web and mobile app for systematic reviews. Syst Rev. 2016;5(1):210. DOI:https://doi.org/10.1186/s13643-016-0384-4.
   PubMedGoogle Scholar
• Dalous J, Pansiot J, Pham H, et al. Use of human umbilical cord blood mononuclear cells to prevent perinatal brain injury: a preclinical study. Stem Cells Dev. 2013;22(1):169–179. DOI:https://doi.org/10.1089/scd.2012.0183.
   PubMed Web of Science ®Google Scholar
• Zhu L, Bai X, Zhang N, et al. Improvement of human umbilical cord mesenchymal stem cell transplantation on glial cell and behavioral function in a neonatal model of periventricular white matter damage. Brain Res. 2014;1563:13–21.
   PubMed Web of Science ®Google Scholar
• Li J, Yawno T, Sutherland A, et al. Preterm white matter brain injury is prevented by early administration of umbilical cord blood cells. Exp Neurol. 2016;283:179–187.
   PubMed Web of Science ®Google Scholar
• Li J, Yawno T, Sutherland A, et al. Term vs. preterm cord blood cells for the prevention of preterm brain injury. Pediatr Res. 2017;82(6):1030–1038. DOI:https://doi.org/10.1038/pr.2017.170.
   PubMed Web of Science ®Google Scholar
• Li J, Yawno T, Sutherland AE, et al. Preterm umbilical cord blood derived mesenchymal stem/stromal cells protect preterm white matter brain development against hypoxia-ischemia. Exp Neurol. 2018;308:120–131.
   PubMed Web of Science ®Google Scholar
• Paton MC, Allison BJ, Li J, et al. Human umbilical cord blood therapy protects cerebral white matter from systemic LPS exposure in preterm fetal sheep. Dev Neurosci. 2018;40(3):258–270. DOI:https://doi.org/10.1159/000490943.
   PubMed Web of Science ®Google Scholar
• Paton MC, Allison BJ, Fahey MC, et al. Umbilical cord blood versus mesenchymal stem cells for inflammation-induced preterm brain injury in fetal sheep. Pediatr Res. 2019;86(2):165–173. DOI:https://doi.org/10.1038/s41390-019-0366-z.
   PubMed Web of Science ®Google Scholar
• Oppliger B, Joerger-Messerli M, Mueller M, et al. Intranasal delivery of umbilical cord-derived mesenchymal stem cells preserves myelination in perinatal brain damage. Stem Cells Dev. 2016;25(16):1234–1242. DOI:https://doi.org/10.1089/scd.2016.0027.
   PubMed Web of Science ®Google Scholar
• Mueller M, Oppliger B, Joerger-Messerli M, et al. Wharton’s jelly mesenchymal stem cells protect the immature brain in rats and modulate cell fate. Stem Cells Dev. 2017;26(4):239–248. DOI:https://doi.org/10.1089/scd.2016.0108.
   PubMed Web of Science ®Google Scholar
• Xie M, Yang Y-J, Liu C-T, et al. Effect of intracerebral transplantation of rat bone marrow stromal cells on brain white matter of neonatal rats with hypoxic-ischemic brain damage. Zhongguo Dang dai er ke za zhi= Chin J Contemp Pediatr. 2008;10(2): 183–187
   PubMedGoogle Scholar
• Chen A, Siow B, Blamire AM, et al. Transplantation of magnetically labeled mesenchymal stem cells in a model of perinatal brain injury. Stem Cell Res. 2010;5(3):255–266. DOI:https://doi.org/10.1016/j.scr.2010.08.004.
   PubMed Web of Science ®Google Scholar
• Jellema RK, Wolfs TG, Lima Passos V, et al. Mesenchymal stem cells induce T-cell tolerance and protect the preterm brain after global hypoxia-ischemia. PLoS one. 2013;8(8):e73031. DOI:https://doi.org/10.1371/journal.pone.0073031.
   PubMed Web of Science ®Google Scholar
• Vaes JE, van Kammen CM, Trayford C, et al. Intranasal mesenchymal stem cell therapy to boost myelination after encephalopathy of prematurity. Glia. 2021;69(3):655–680. DOI:https://doi.org/10.1002/glia.23919.
   PubMed Web of Science ®Google Scholar
• Jellema RK, Ophelders DRG, Zwanenburg A, et al. Multipotent adult progenitor cells for hypoxic-ischemic injury in the preterm brain. J Neuroinflammation. 2015;12(1):1–14. DOI:https://doi.org/10.1186/s12974-015-0459-5.
   Google Scholar
• Webber DJ, Van Blitterswijk M, Chandran S. Neuroprotective effect of oligodendrocyte precursor cell transplantation in a long-term model of periventricular leukomalacia. Am J Pathol. 2009;175(6):2332–2342.
   PubMed Web of Science ®Google Scholar
• Porambo M, Phillips AW, Marx J, et al. Transplanted glial restricted precursor cells improve neurobehavioral and neuropathological outcomes in a mouse model of neonatal white matter injury despite limited cell survival. Glia. 2015;63(3):452–465. DOI:https://doi.org/10.1002/glia.22764.
   PubMed Web of Science ®Google Scholar
• Chen L-X, S-m M, Zhang P, et al. Neuroprotective effects of oligodendrocyte progenitor cell transplantation in premature rat brain following hypoxic-ischemic injury. PLoS One. 2015;10(3):e0115997. DOI:https://doi.org/10.1371/journal.pone.0115997.
   PubMed Web of Science ®Google Scholar
• C-j W, Wang Z-Y, Yang Y-X, et al. Long-term effect of oligodendrocyte precursor cell transplantation on a rat model of white matter injury in the preterm infant. Zhongguo Dang Dai Er Ke Za Zhi. 2017;19(9): 1003–1007
   PubMedGoogle Scholar
• Kim T-K, Park D, Ban Y-H, et al. Improvement by human oligodendrocyte progenitor cells of neurobehavioral disorders in an experimental model of neonatal periventricular leukomalacia. Cell Transplant. 2018;27(7):1168–1177. DOI:https://doi.org/10.1177/0963689718781330.
   PubMed Web of Science ®Google Scholar
• Ogawa S, Hagiwara M, Misumi S, et al. Transplanted oligodendrocyte progenitor cells survive in the brain of a rat neonatal white matter injury model but less mature in comparison with the normal brain. Cell Transplant. 2020 0963689720946092;29:096368972094609. DOI:https://doi.org/10.1177/0963689720946092.
   Web of Science ®Google Scholar
• Yawno T, Sabaretnam T, Li J, et al. Human amnion epithelial cells protect against white matter brain injury after repeated endotoxin exposure in the preterm ovine fetus. Cell Transplant. 2017;26(4):541–553. DOI:https://doi.org/10.3727/096368916X693572.
   PubMed Web of Science ®Google Scholar
• Y-q H, Chen H-J, Qian L-H, et al. Cerebral pathological evaluation following neural stem cells intraventricular transplantation in neonatal rats with periventricular leukomalacia. Zhongguo Dang Dai Er Ke Za Zhi. 2008;10(3): 362–366
   PubMedGoogle Scholar
• Borhani-Haghighi M, Mohamadi Y, Kashani IR. In utero transplantation of neural stem cells ameliorates maternal inflammation-induced prenatal white matter injury. J Cell Biochem. 2019;120(8):12785–12795.
   PubMed Web of Science ®Google Scholar
• Ophelders DR, Wolfs TG, Jellema RK, et al. Mesenchymal stromal cell-derived extracellular vesicles protect the fetal brain after hypoxia-ischemia. Stem Cells Transl Med. 2016;5(6):754–763. DOI:https://doi.org/10.5966/sctm.2015-0197.
   PubMed Web of Science ®Google Scholar
• Drommelschmidt K, Serdar M, Bendix I, et al. Mesenchymal stem cell-derived extracellular vesicles ameliorate inflammation-induced preterm brain injury. Brain Behav Immun. 2017;60:220–232.
   PubMed Web of Science ®Google Scholar
• Morioka C, Komaki M, Taki A, et al. Neuroprotective effects of human umbilical cord-derived mesenchymal stem cells on periventricular leukomalacia-like brain injury in neonatal rats. Inflamm Regen. 2017;37(1):1–10. DOI:https://doi.org/10.1186/s41232-016-0032-3.
   PubMedGoogle Scholar
• Thomi G, Joerger-Messerli M, Haesler V, et al. Intranasally administered exosomes from umbilical cord stem cells have preventive neuroprotective effects and contribute to functional recovery after perinatal brain injury. Cells. 2019;8(8):855. DOI:https://doi.org/10.3390/cells8080855.
   PubMed Web of Science ®Google Scholar
• Yin L, Wang S, Zhang N, et al. Elevation of stromal cell-derived factor 1 and C-X-C chemokine receptor type 4 in white matter damage treatment with recombinant human erythropoietin and human umbilical cord mesenchymal stem cells in a rat model of preterm birth. Int J Dev Neurosci. 2020;80(3):247–256. DOI:https://doi.org/10.1002/jdn.10021.
   PubMed Web of Science ®Google Scholar
• Keller M, Yang J, Griesmaier E, et al. Erythropoietin is neuroprotective against NMDA-receptor-mediated excitotoxic brain injury in newborn mice. Neurobiol Dis. 2006;24(2):357–366. DOI:https://doi.org/10.1016/j.nbd.2006.07.007.
   PubMed Web of Science ®Google Scholar
• Kumral A, Baskin H, Yesilirmak DC, et al. Erythropoietin attenuates lipopolysaccharide-induced white matter injury in the neonatal rat brain. Neonatology. 2007;92(4):269–278. DOI:https://doi.org/10.1159/000105493.
   PubMed Web of Science ®Google Scholar
• Mizuno K, Hida H, Masuda T, et al. Pretreatment with low doses of erythropoietin ameliorates brain damage in periventricular leukomalacia by targeting late oligodendrocyte progenitors: a rat model. Neonatology. 2008;94(4):255–266. DOI:https://doi.org/10.1159/000151644.
   PubMed Web of Science ®Google Scholar
• Shen Y, H-M Y, Yuan T-M, et al. Erythropoietin attenuates white matter damage, proinflammatory cytokine and chemokine induction in developing rat brain after intra-uterine infection. Neuropathology. 2009;29(5):528–535. DOI:https://doi.org/10.1111/j.1440-1789.2009.01005.x.
   PubMed Web of Science ®Google Scholar
• Iwai M, Stetler RA, Xing J, et al. Enhanced oligodendrogenesis and recovery of neurological function by erythropoietin after neonatal hypoxic/ischemic brain injury. Stroke. 2010;41(5):1032–1037. DOI:https://doi.org/10.1161/STROKEAHA.109.570325.
   PubMed Web of Science ®Google Scholar
• Zhou W, Rong X, Tao L, et al. Recombinant human erythropoietin for repair of white matter damage**. Neural Regen Res. 2011;6:635–640.
   Web of Science ®Google Scholar
• Liu W, Shen Y, Plane JM, et al. Neuroprotective potential of erythropoietin and its derivative carbamylated erythropoietin in periventricular leukomalacia. Exp Neurol. 2011;230(2):227–239. DOI:https://doi.org/10.1016/j.expneurol.2011.04.021.
   PubMed Web of Science ®Google Scholar
• Kako E, Kaneko N, Aoyama M, et al. Subventricular zone-derived oligodendrogenesis in injured neonatal white matter in mice enhanced by a nonerythropoietic erythropoietin derivative. Stem Cells. 2012;30(10):2234–2247. DOI:https://doi.org/10.1002/stem.1202.
   PubMed Web of Science ®Google Scholar
• Wang T, Hu Y, Leach MK, et al. Erythropoietin-loaded oligochitosan nanoparticles for treatment of periventricular leukomalacia. Int J Pharm. 2012;422(1–2):462–471. DOI:https://doi.org/10.1016/j.ijpharm.2011.10.058.
   PubMed Web of Science ®Google Scholar
• Jantzie LL, Miller RH, Robinson S. Erythropoietin signaling promotes oligodendrocyte development following prenatal systemic hypoxic–ischemic brain injury. Pediatr Res. 2013;74(6):658–667.
   PubMed Web of Science ®Google Scholar
• Jantzie LL, Corbett CJ, Firl DJ, et al. Postnatal erythropoietin mitigates impaired cerebral cortical development following subplate loss from prenatal hypoxia–ischemia. Cereb Cortex. 2015;25(9):2683–2695. DOI:https://doi.org/10.1093/cercor/bhu066.
   PubMed Web of Science ®Google Scholar
• Hoeber D, Sifringer M, Van De Looij Y, et al. Erythropoietin restores long-term neurocognitive function involving mechanisms of neuronal plasticity in a model of hyperoxia-induced preterm brain injury. Oxid Med Cell Longev 2016. 2016; 2016: 1–13. https://doi.org/10.1155/2016/9247493
   Web of Science ®Google Scholar
• Ren Q, Zhang X, Yang J. Erythropoietin reduces white matter damage in two-day-old rats exposed to hypoxic/ischemia injury. Neurol Res. 2016;38(11):1020–1026.
   PubMed Web of Science ®Google Scholar
• Yuan QC, Jiang L, Zhu LH, et al. Impacts of erythropoietin on vascular endothelial growth factor receptor 2 by the extracellular signal-regulated kinase signaling pathway in a neonatal rat model of periventricular white matter damage. Zhongguo yi xue ke xue Yuan xue bao. Acta Academiae Medicinae Sinicae. 2016;38(2):217–221. DOI:https://doi.org/10.3881/j.issn.1000-503X.2016.02.016
   Google Scholar
• Chan KY, LaRosa DA, Tolcos M, et al. Optimizing the dose of erythropoietin required to prevent acute ventilation-induced cerebral white matter injury in preterm lambs. Dev Neurosci. 2017;39(1–4):298–309. DOI:https://doi.org/10.1159/000459620.
   PubMed Web of Science ®Google Scholar
• Dewan MV, Serdar M, van de Looij Y, et al. Repetitive erythropoietin treatment improves long-term neurocognitive outcome by attenuating hyperoxia-induced hypomyelination in the developing brain. Front Neurol. 2020;11:11.
   PubMed Web of Science ®Google Scholar
• Husson I, Mesples B, Bac P, et al. Melatoninergic neuroprotection of the murine periventricular white matter against neonatal excitotoxic challenge. Ann Neurol. 2002;51(1):82–92. DOI:https://doi.org/10.1002/ana.10072.
   PubMed Web of Science ®Google Scholar
• Watanabe K, Wakatsuki A, Shinohara K, et al. Maternally administered melatonin protects against ischemia and reperfusion-induced oxidative mitochondrial damage in premature fetal rat brain. J Pineal Res. 2004;37(4):276–280. DOI:https://doi.org/10.1111/j.1600-079X.2004.00167.x.
   PubMed Web of Science ®Google Scholar
• Miller SL, Yan EB, Castillo-Meléndez M, et al. Melatonin provides neuroprotection in the late-gestation fetal sheep brain in response to umbilical cord occlusion. Dev Neurosci. 2005;27(2–4):200–210. DOI:https://doi.org/10.1159/000085993.
   PubMed Web of Science ®Google Scholar
• Welin A-K, Svedin P, Lapatto R, et al. Melatonin reduces inflammation and cell death in white matter in the mid-gestation fetal sheep following umbilical cord occlusion. Pediatr Res. 2007;61(2):153–158. DOI:https://doi.org/10.1203/01.pdr.0000252546.20451.1a.
   PubMed Web of Science ®Google Scholar
• Bouslama M, Renaud J, Olivier P, et al. Melatonin prevents learning disorders in brain-lesioned newborn mice. Neuroscience. 2007;150(3):712–719. DOI:https://doi.org/10.1016/j.neuroscience.2007.09.030.
   PubMed Web of Science ®Google Scholar
• Gressens P, Schwendimann L, Husson I, et al. Agomelatine, a melatonin receptor agonist with 5-HT2C receptor antagonist properties, protects the developing murine white matter against excitotoxicity. Eur J Pharmacol. 2008;588(1):58–63. DOI:https://doi.org/10.1016/j.ejphar.2008.04.016.
   PubMed Web of Science ®Google Scholar
• Olivier P, Fontaine RH, Loron G, et al. Melatonin promotes oligodendroglial maturation of injured white matter in neonatal rats. PloS one. 2009;4(9):e7128. DOI:https://doi.org/10.1371/journal.pone.0007128.
   PubMed Web of Science ®Google Scholar
• Kaur C, Sivakumar V, Ling EA. Melatonin protects periventricular white matter from damage due to hypoxia. J Pineal Res. 2010;48(3):185–193.
   PubMed Web of Science ®Google Scholar
• Drury PP, Davidson JO, Bennet L, et al. Partial neural protection with prophylactic low-dose melatonin after asphyxia in preterm fetal sheep. J Cereb Blood Flow Metab. 2014;34(1):126–135. DOI:https://doi.org/10.1038/jcbfm.2013.174.
   PubMed Web of Science ®Google Scholar
• Moretti R, Zanin A, Pansiot J, et al. Melatonin reduces excitotoxic blood–brain barrier breakdown in neonatal rats. Neuroscience. 2015;311:382–397.
   PubMed Web of Science ®Google Scholar
• Yawno T, Mahen M, Li J, et al. The beneficial effects of melatonin administration following hypoxia-ischemia in preterm fetal sheep. Front Cell Neurosci. 2017;11:296.
   PubMed Web of Science ®Google Scholar
• Hu Y, Wang Z, Pan S, et al. Melatonin protects against blood-brain barrier damage by inhibiting the TLR4/NF-κB signaling pathway after LPS treatment in neonatal rats. Oncotarget. 2017;8(19):31638. DOI:https://doi.org/10.18632/oncotarget.15780.
   PubMedGoogle Scholar
• Lin S, Fan L-W, Pang Y, et al. IGF-1 protects oligodendrocyte progenitor cells and improves neurological functions following cerebral hypoxia–ischemia in the neonatal rat. Brain Res. 2005;1063(1):15–26. DOI:https://doi.org/10.1016/j.brainres.2005.09.042.
   PubMed Web of Science ®Google Scholar
• Wood TL, Loladze V, Altieri S, et al. Delayed IGF-1 administration rescues oligodendrocyte progenitors from glutamate-induced cell death and hypoxic-ischemic brain damage. Dev Neurosci. 2007;29(4–5):302–310. DOI:https://doi.org/10.1159/000105471.
   PubMed Web of Science ®Google Scholar
• Pang Y, Zheng B, Campbell LR, et al. IGF-1 can either protect against or increase LPS-induced damage in the developing rat brain. Pediatr Res. 2010;67(6):579–584. DOI:https://doi.org/10.1203/PDR.0b013e3181dc240f.
   PubMed Web of Science ®Google Scholar
• Cai Z, Fan L-W, Lin S, et al. Intranasal administration of insulin-like growth factor-1 protects against lipopolysaccharide-induced injury in the developing rat brain. Neuroscience. 2011;194:195–207.
   PubMed Web of Science ®Google Scholar
• Scafidi J, Hammond TR, Scafidi S, et al. Intranasal epidermal growth factor treatment rescues neonatal brain injury. Nature. 2014;506(7487):230–234. DOI:https://doi.org/10.1038/nature12880.
   PubMed Web of Science ®Google Scholar
• Fan L-W, Pang Y, Lin S, et al. Minocycline attenuates lipopolysaccharide-induced white matter injury in the neonatal rat brain. Neuroscience. 2005;133(1):159–168. DOI:https://doi.org/10.1016/j.neuroscience.2005.02.016.
   PubMed Web of Science ®Google Scholar
• Fan L-W, Pang Y, Lin S, et al. Minocycline reduces lipopolysaccharide-induced neurological dysfunction and brain injury in the neonatal rat. J Neurosci Res. 2005;82(1):71–82. DOI:https://doi.org/10.1002/jnr.20623.
   PubMed Web of Science ®Google Scholar
• Fan L-W, Lin S, Pang Y, et al. Minocycline attenuates hypoxia–ischemia-induced neurological dysfunction and brain injury in the juvenile rat. Eur J Neurosci. 2006;24(2):341–350. DOI:https://doi.org/10.1111/j.1460-9568.2006.04918.x.
   PubMed Web of Science ®Google Scholar
• Cai Z, Lin S, Fan L-W, et al. Minocycline alleviates hypoxic–ischemic injury to developing oligodendrocytes in the neonatal rat brain. Neuroscience. 2006;137(2):425–435. DOI:https://doi.org/10.1016/j.neuroscience.2005.09.023.
   PubMed Web of Science ®Google Scholar
• Carty ML, Wixey JA, Colditz PB, et al. Post-insult minocycline treatment attenuates hypoxia-ischemia-induced neuroinflammation and white matter injury in the neonatal rat: a comparison of two different dose regimens. Int J Dev Neurosci. 2008;26(5):477–485. DOI:https://doi.org/10.1016/j.ijdevneu.2008.02.005.
   PubMed Web of Science ®Google Scholar
• Lechpammer M, Manning SM, Samonte F, et al. Minocycline treatment following hypoxic/ischaemic injury attenuates white matter injury in a rodent model of periventricular leucomalacia. Neuropathol Appl Neurobiol. 2008;34(4):379–393. DOI:https://doi.org/10.1111/j.1365-2990.2007.00925.x.
   PubMed Web of Science ®Google Scholar
• Zou XP, Li XY, Li LL, et al. Role of minocycline in an immature rat model of hypoxic-ischemic brain damage. Zhonghua er ke za zhi= Chin J Pediatr. 2010;48(11):848–854.
   PubMedGoogle Scholar
• Schmitz T, Krabbe G, Weikert G, et al. Minocycline protects the immature white matter against hyperoxia. Exp Neurol. 2014;254:153–165.
   PubMed Web of Science ®Google Scholar
• Nuñez JL, McCarthy MM. Estradiol exacerbates hippocampal damage in a model of preterm infant brain injury. Endocrinology. 2003;144(6):2350–2359.
   PubMed Web of Science ®Google Scholar
• McClean J, Nuñez JL. 17α-Estradiol is neuroprotective in male and female rats in a model of early brain injury. Exp Neurol. 2008;210(1):41–50.
   PubMed Web of Science ®Google Scholar
• Gerstner B, Lee J, DeSilva TM, et al. 17β-estradiol protects against hypoxic/ischemic white matter damage in the neonatal rat brain. J Neurosci Res. 2009;87(9):2078–2086. DOI:https://doi.org/10.1002/jnr.22023.
   PubMed Web of Science ®Google Scholar
• Pansiot J, Pham H, Dalous J, et al. Glial response to 17β-estradiol in neonatal rats with excitotoxic brain injury. Exp Neurol. 2016;282:56–65.
   PubMed Web of Science ®Google Scholar
• Liu G, Yan Y, Shi B, et al. Benefits of progesterone on brain immaturity and white matter injury induced by chronic hypoxia in neonatal rats. J Thorac Cardiovasc Surg. 2020;160(2):e55–66. DOI:https://doi.org/10.1016/j.jtcvs.2020.03.057.
   PubMed Web of Science ®Google Scholar
• Sárközy G, Griesmaier E, He X, et al. T3 replacement does not prevent excitotoxic cell death but reduces developmental neuronal apoptosis in newborn mice. Eur J Paediatr Neurol. 2007;11(3):129–135. DOI:https://doi.org/10.1016/j.ejpn.2006.11.009.
   PubMed Web of Science ®Google Scholar
• Hung P-L, Huang -C-C, Huang H-M, et al. Thyroxin treatment protects against white matter injury in the immature brain via brain-derived neurotrophic factor. Stroke. 2013;44(8):2275–2283. DOI:https://doi.org/10.1161/STROKEAHA.113.001552.
   PubMed Web of Science ®Google Scholar
• Schang A-L, Van Steenwinckel J, Chevenne D, et al. Failure of thyroid hormone treatment to prevent inflammation-induced white matter injury in the immature brain. Brain Behav Immun. 2014;37:95–102.
   PubMed Web of Science ®Google Scholar
• Espinosa-Jeffrey A, Barajas SA, Arrazola AR, et al. White matter loss in a mouse model of periventricular leukomalacia is rescued by trophic factors. Brain Sci. 2013;3(4):1461–1482. DOI:https://doi.org/10.3390/brainsci3041461.
   PubMedGoogle Scholar
• Hirose-Ikeda M, Chu B, Zhao P, et al. Trophic factors are essential for the survival of grafted oligodendrocyte progenitors and for neuroprotection after perinatal excitotoxicity. Neural Regen Res. 2020;15(3):557–568. DOI:https://doi.org/10.4103/1673-5374.266066.
   PubMed Web of Science ®Google Scholar
• Arquié C, Leroux P, Bodenant C, et al. Glucocorticoid treatment in an ischaemic-like excitotoxic model of periventricular leucomalacia in mice. Bjog. 2002;109(9):989–996. DOI:https://doi.org/10.1111/j.1471-0528.2002.01202.x.
   PubMed Web of Science ®Google Scholar
• Su X, Yuan H, Bai Y, et al. Clobetasol attenuates white matter injury by promoting oligodendrocyte precursor cell differentiation. Pediatr Neurosurg. 2020;55(4):188–196. DOI:https://doi.org/10.1159/000509521.
   PubMed Web of Science ®Google Scholar
• Fernández-López D, Pradillo JM, García-Yébenes I, et al. The cannabinoid WIN55212-2 promotes neural repair after neonatal hypoxia–ischemia. Stroke. 2010;41(12):2956–2964. DOI:https://doi.org/10.1161/STROKEAHA.110.599357.
   PubMed Web of Science ®Google Scholar
• Carloni S, Crinelli R, Palma L, et al. The synthetic cannabinoid URB447 reduces brain injury and the associated white matter demyelination after hypoxia-ischemia in neonatal rats. ACS Chem Neurosci. 2020;11(9):1291–1299. DOI:https://doi.org/10.1021/acschemneuro.0c00047.
   PubMed Web of Science ®Google Scholar
• Tuzun F, Kumral A, Dilek M, et al. Maternal omega-3 fatty acid supplementation protects against lipopolysaccharide-induced white matter injury in the neonatal rat brain. J Matern Fetal Neonatal Med. 2012;25(6):849–854. DOI:https://doi.org/10.3109/14767058.2011.587917.
   PubMed Web of Science ®Google Scholar
• Shi J, Fu W, Liu J. Omega-3 PUFA Attenuates LPS-Induced Neuro-Injury of Neonatal Rats through the PI3K/AKT Pathway. Neuroscience. 2019;414:112–127.
   PubMed Web of Science ®Google Scholar
• Mao F, Li W, Chen H, et al. Periventricular leukomalacia long-term prognosis may be improved by treatment with UDP-glucose, GDNF, and memantine in neonatal rats. Brain Res. 2012;1486:112–120.
   PubMed Web of Science ®Google Scholar
• W-J L, Mao F-X, Chen H-J, et al. Effect of single or combined application of UDP-glucose, GDNF and memantine on improvement of white matter injury in neonatal rats assessed with light and electron microscopy pathologically. Zhongguo Dang Dai Er Ke Za Zhi. 2012;14(12):964–970.
   PubMedGoogle Scholar
• W-J L, Mao F-X, Chen H-J, et al. Treatment with UDP-glucose, GDNF, and memantine promotes SVZ and white matter self-repair by endogenous glial progenitor cells in neonatal rats with ischemic PVL. Neuroscience. 2015;284:444–458.
   PubMed Web of Science ®Google Scholar
• Paintlia MK, Paintlia AS, Barbosa E, et al. N-acetylcysteine prevents endotoxin-induced degeneration of oligodendrocyte progenitors and hypomyelination in developing rat brain. J Neurosci Res. 2004;78(3):347–361. DOI:https://doi.org/10.1002/jnr.20261.
   PubMed Web of Science ®Google Scholar
• Chang EY, Zhang J, Sullivan S, et al. Nacetylcysteine attenuates the maternal and fetal proinflammatory response to intrauterine LPS injection in an animal model for preterm birth and brain injury. J Matern Fetal Neonatal Med. 2011;24(5):732–740. DOI:https://doi.org/10.3109/14767058.2010.528089.
   PubMed Web of Science ®Google Scholar
• Beloosesky R, Ginsberg Y, Khatib N, et al. Prophylactic maternal N-acetylcysteine in rats prevents maternal inflammation–induced offspring cerebral injury shown on magnetic resonance imaging. Am J Obstet Gynecol. 2013;208(3):213–e1. DOI:https://doi.org/10.1016/j.ajog.2013.01.023.
   PubMed Web of Science ®Google Scholar
• Sharabi H, Khatib N, Ginsberg Y, et al. Therapeutic N-acetyl-cysteine (Nac) following initiation of maternal inflammation attenuates long-term offspring cerebral injury, as evident in magnetic resonance imaging (MRI). Neuroscience. 2019;403:118–124.
   PubMed Web of Science ®Google Scholar
• Lin S, Rhodes PG, Lei M, et al. α-Phenyl-n-tert-butyl-nitrone attenuates hypoxic–ischemic white matter injury in the neonatal rat brain. Brain Res. 2004;1007(1–2):132–141. DOI:https://doi.org/10.1016/j.brainres.2004.01.074.
   PubMed Web of Science ®Google Scholar
• Fan L-W, Mitchell HJ, Tien L-T, et al. α-Phenyl-n-tert-butyl-nitrone reduces lipopolysaccharide-induced white matter injury in the neonatal rat brain. Dev Neurobiol. 2008;68(3):365–378. DOI:https://doi.org/10.1002/dneu.20591.
   PubMed Web of Science ®Google Scholar
• Cai Q, Ma T, Tian Y, et al. Catalpol inhibits ischemia-induced premyelinating oligodendrocyte damage through regulation of intercellular calcium homeostasis via Na+/Ca2+ exchanger 3. Int J Mol Sci. 2018;19(7):1925. DOI:https://doi.org/10.3390/ijms19071925.
   Web of Science ®Google Scholar
• Carty ML, Wixey JA, Reinebrant HE, et al. Ibuprofen inhibits neuroinflammation and attenuates white matter damage following hypoxia–ischemia in the immature rodent brain. Brain Res. 2011;1402:9–19.
   PubMed Web of Science ®Google Scholar
• Cho KH, Wassink G, Galinsky R, et al. Protective effects of delayed intraventricular TLR7 agonist administration on cerebral white and gray matter following asphyxia in the preterm fetal sheep. Sci Rep. 2019;9(1):1–17. DOI:https://doi.org/10.1038/s41598-019-45872-y.
   PubMedGoogle Scholar
• Dean JM, George SA, Wassink G, et al. Suppression of post-hypoxic-ischemic EEG transients with dizocilpine is associated with partial striatal protection in the preterm fetal sheep. Neuropharmacology. 2006;50(4):491–503. DOI:https://doi.org/10.1016/j.neuropharm.2005.10.017.
   PubMed Web of Science ®Google Scholar
• Doverhag C, Keller M, Karlsson A, et al. Pharmacological and genetic inhibition of NADPH oxidase does not reduce brain damage in different models of perinatal brain injury in newborn mice. Neurobiol Dis. 2008;31(1):133–144. DOI:https://doi.org/10.1016/j.nbd.2008.04.003.
   PubMed Web of Science ®Google Scholar
• Drury PP, Davidson JO, van den Heuij LG, et al. Partial neuroprotection by nNOS inhibition during profound asphyxia in preterm fetal sheep. Exp Neurol. 2013;250:282–292.
   PubMed Web of Science ®Google Scholar
• Fan L-W, Kaizaki A, Tien L-T, et al. Celecoxib attenuates systemic lipopolysaccharide-induced brain inflammation and white matter injury in the neonatal rats. Neuroscience. 2013;240:27–38.
   PubMed Web of Science ®Google Scholar
• Furukawa S, Yang L, Sameshima H, et al. Repetitive administration of acetylcholine receptor agonist rescues brain inflammation and brain damage after hypoxia-ischemia in newborn rat. J Perinat Med. 2014;42(3):379–384. DOI:https://doi.org/10.1515/jpm-2013-0175.
   PubMed Web of Science ®Google Scholar
• Albertsson A-M, Zhang X, Leavenworth J, et al. The effect of osteopontin and osteopontin-derived peptides on preterm brain injury. J Neuroinflammation. 2014;11(1):1–13. DOI:https://doi.org/10.1186/s12974-014-0197-0.
   PubMedGoogle Scholar
• Back SA, Craig A, Ling Luo N, et al. Protective effects of caffeine on chronic hypoxia-induced perinatal white matter injury. Ann Neurol. 2006;60(6):696–705. DOI:https://doi.org/10.1002/ana.21008.
   PubMed Web of Science ®Google Scholar
• Pham H, Vottier G, Pansiot J, et al. Inhaled NO prevents hyperoxia-induced white matter damage in neonatal rats. Exp Neurol. 2014;252:114–123.
   PubMed Web of Science ®Google Scholar
• Pham H, Duy AP, Pansiot J, et al. Impact of inhaled nitric oxide on white matter damage in growth-restricted neonatal rats. Pediatr Res. 2015;77(4):563–569. DOI:https://doi.org/10.1038/pr.2015.4.
   PubMed Web of Science ®Google Scholar
• Du Y, Yao LL, Yang Y, et al. Granulocyte-colony stimulating factor ameliorates periventricular white matter damage subject to hypoxia via influencing on activation of microglia. Acta Anat. 2013;44:163–169.
   Google Scholar
• Jellema RK, Passos VL, Ophelders DR, et al. Systemic G-CSF attenuates cerebral inflammation and hypomyelination but does not reduce seizure burden in preterm sheep exposed to global hypoxia–ischemia. Exp Neurol. 2013;250:293–303.
   PubMed Web of Science ®Google Scholar
• Fogal B, McClaskey C, Yan S, et al. Diazoxide promotes oligodendrocyte precursor cell proliferation and myelination. PloS one. 2010;5(5):e10906. DOI:https://doi.org/10.1371/journal.pone.0010906.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Wendler CC, Shi O, et al. Diazoxide promotes oligodendrocyte differentiation in neonatal brain in normoxia and chronic sublethal hypoxia. Brain Res. 2014;1586:64–72.
   PubMed Web of Science ®Google Scholar
• Rodts-Palenik S, Wyatt-Ashmead J, Pang Y, et al. Maternal infection-induced white matter injury is reduced by treatment with interleukin-10. Am J Obstet Gynecol. 2004;191(4):1387–1392. DOI:https://doi.org/10.1016/j.ajog.2004.06.093.
   PubMed Web of Science ®Google Scholar
• Pang Y, Rodts-Palenik S, Cai Z, et al. Suppression of glial activation is involved in the protection of IL-10 on maternal E. coli induced neonatal white matter injury. Dev Brain Res. 2005;157(2):141–149. DOI:https://doi.org/10.1016/j.devbrainres.2005.03.015.
   PubMedGoogle Scholar
• Ginet V, Van De Looij Y, Petrenko V, et al. Lactoferrin during lactation reduces lipopolysaccharide-induced brain injury. BioFactors. 2016;42(3):323–336. DOI:https://doi.org/10.1002/biof.1278.
   PubMed Web of Science ®Google Scholar
• Guardia Clausi M, Paez PM, Campagnoni AT, et al. Intranasal administration of aTf protects and repairs the neonatal white matter after a cerebral hypoxic–ischemic event. Glia. 2012;60(10):1540–1554. DOI:https://doi.org/10.1002/glia.22374.
   PubMed Web of Science ®Google Scholar
• Gressens P, Marret S, Martin J-L, et al. Regulation of neuroprotective action of vasoactive intestinal peptide in the murine developing brain by protein kinase C and mitogen-activated protein kinase cascades: in vivo and in vitro studies. J Neurochem. 1998;70(6):2574–2584. DOI:https://doi.org/10.1046/j.1471-4159.1998.70062574.x.
   PubMed Web of Science ®Google Scholar
• Gressens P, Besse L, Robberecht P, et al. Neuroprotection of the developing brain by systemic administration of vasoactive intestinal peptide derivatives. J Pharmacol Exp Ther. 1999;288(3):1207–1213.
   PubMed Web of Science ®Google Scholar
• Y-f H, Chen H-J, Qian L-H, et al. 1400W blocks death pathway of LPS-induced activated-microglia to preOLs. Zhongguo Dang dai er ke za zhi= Chin J Contemp Pediatr. 2010;12(5):357–362.
   PubMedGoogle Scholar
• He Y, Chen H, Qian L, et al. Diphenyleneiodonium protects preoligodendrocytes against endotoxin-activated microglial NADPH oxidase-generated peroxynitrite in a neonatal rat model of periventricular leukomalacia. Brain Res. 2013;1492:108–121.
   PubMed Web of Science ®Google Scholar
• Hu Y, Shao XM, Wang Y, et al. Protective effects of allopurinol on white matter damage in premature rats. Zhonghua er ke za zhi= Chin J Pediatri. 2006;44(3):182–186.
   PubMedGoogle Scholar
• Huang J, Zhang L, Qu Y, et al. Histone acetylation of oligodendrocytes protects against white matter injury induced by inflammation and hypoxia-ischemia through activation of BDNF-TrkB signaling pathway in neonatal rats. Brain Res. 2018;1688:33–46.
   PubMed Web of Science ®Google Scholar
• Husson I, Rangon C-M, Lelièvre V, et al. BDNF-induced white matter neuroprotection and stage-dependent neuronal survival following a neonatal excitotoxic challenge. Cereb Cortex. 2005;15(3):250–261. DOI:https://doi.org/10.1093/cercor/bhh127.
   PubMed Web of Science ®Google Scholar
• Jantzie LL, Hu MY, Park H-K, et al. Chloride cotransporter NKCC1 inhibitor bumetanide protects against white matter injury in a rodent model of periventricular leukomalacia. Pediatr Res. 2015;77(4):554–562. DOI:https://doi.org/10.1038/pr.2015.9.
   PubMed Web of Science ®Google Scholar
• Jia L, Wang J, Cao H, et al. Activation of PGC-1α and mitochondrial biogenesis protects against prenatal hypoxic–ischemic brain injury. Neuroscience. 2020;432:63–72.
   PubMed Web of Science ®Google Scholar
• Huang -J-J, Liu X, Wang X-Q, et al. Effects of quercetin on the learning and memory ability of neonatal rats with hypoxic-ischemic brain damage. Zhongguo Dang Dai Er Ke Za Zhi. 2012;14(6): 454–457
   PubMedGoogle Scholar
• Kumral A, Iscan B, Engur D, et al. Intranasal surfactant protein D as neuroprotective rescue in a neonatal rat model of periventricular leukomalacia. J Matern Fetal Neonatal Med. 2017;30(4):446–451. DOI:https://doi.org/10.1080/14767058.2016.1174996.
   PubMed Web of Science ®Google Scholar
• Leroux P, Hennebert O, Legros H, et al. Role of tissue-plasminogen activator (t-PA) in a mouse model of neonatal white matter lesions: interaction with plasmin inhibitors and anti-inflammatory drugs. Neuroscience. 2007;146(2):670–678. DOI:https://doi.org/10.1016/j.neuroscience.2007.01.029.
   PubMed Web of Science ®Google Scholar
• Lin J, Niimi Y, Clausi MG, et al. Neuroregenerative and protective functions of Leukemia Inhibitory Factor in perinatal hypoxic-ischemic brain injury. Exp Neurol. 2020;330:113324.
   PubMed Web of Science ®Google Scholar
• Liu GJ, Ji L, Wang DG, et al. Effects of gamma-secretase inhibitor DAPT on inflammation-induced white matter damage in neonatal mice. Chin Pharm J. 2018;53:1083–1087.
   Google Scholar
• Manning SM, Talos DM, Zhou C, et al. NMDA receptor blockade with memantine attenuates white matter injury in a rat model of periventricular leukomalacia. J Neurosci. 2008;28(26):6670–6678. DOI:https://doi.org/10.1523/JNEUROSCI.1702-08.2008.
   PubMed Web of Science ®Google Scholar
• Rangon C-M, Schang A-L, Van Steenwinckel J, et al. Myelination induction by a histamine H3 receptor antagonist in a mouse model of preterm white matter injury. Brain Behav Immun. 2018;74:265–276.
   PubMed Web of Science ®Google Scholar
• Shin SH, Kim E-K, Lee K, et al. TNF-α antagonist attenuates systemic lipopolysaccharide-induced brain white matter injury in neonatal rats. BMC Neurosci. 2019;20(1):1–9. DOI:https://doi.org/10.1186/s12868-019-0529-1.
   PubMed Web of Science ®Google Scholar
• Sokolowska P, Passemard S, Mok A, et al. Neuroprotective effects of NAP against excitotoxic brain damage in the newborn mice: implications for cerebral palsy. Neuroscience. 2011;173:156–168.
   PubMed Web of Science ®Google Scholar
• Su X, Tang W, Luan Z, et al. Protective effect of miconazole on rat myelin sheaths following premature infant cerebral white matter injury. Exp Ther Med. 2018;15(3):2443–2449. DOI:https://doi.org/10.3892/etm.2018.5717.
   PubMed Web of Science ®Google Scholar
• Tüzün F, Gencpınar P, Ozbal S, et al. Neuroprotective effect of neotrofin in a neonatal rat model of periventricular leukomalacia. Neurosci Lett. 2012;520(1):6–10. DOI:https://doi.org/10.1016/j.neulet.2012.04.076.
   PubMed Web of Science ®Google Scholar
• Wang Y, Li B, Li Z, et al. Improvement of hypoxia–ischemia-induced white matter injury in immature rat brain by ethyl pyruvate. Neurochem Res. 2013;38(4):742–752. DOI:https://doi.org/10.1007/s11064-013-0972-9.
   PubMed Web of Science ®Google Scholar
• Wu Z, Xue H, Zhang Y, et al. Dexmedetomidine alleviates neurobehavioral impairments and myelination deficits following lipopolysaccharide exposure in early postnatal rats. Life Sci. 2020;263:118556.
   PubMed Web of Science ®Google Scholar
• X-y Y, Wang D-Y, Xu Y, et al. Effect of pranlukast on neonatal rats with periventricular leukomalacia. Zhongguo Dang dai er ke za zhi= Chin J Contemp Pediatri. 2020;22(6):656–661.
   PubMedGoogle Scholar
• Yellowhair TR, Newville JC, Noor S, et al. CXCR2 blockade mitigates neural cell injury following preclinical chorioamnionitis. Front Physiol. 2019;10:324.
   PubMed Web of Science ®Google Scholar
• Yesilirmak DC, Kumral A, Baskin H, et al. Activated protein C reduces endotoxin-induced white matter injury in the developing rat brain. Brain Res. 2007;1164:14–23.
   PubMed Web of Science ®Google Scholar
• Yin X, Zhao J, Jiang H, et al. Impact of xenon on CLIC4 and Bcl-2 expression in lipopolysaccharide and hypoxia-ischemia-induced periventricular white matter damage. Neonatology. 2018;113(4):339–346. DOI:https://doi.org/10.1159/000487220.
   PubMed Web of Science ®Google Scholar
• Yu L, Miao J, Li W, et al. Intranasal IL-4 administration alleviates functional deficits of periventricular leukomalacia in neonatal mice. Front Neurol. 2020;11:930.
   PubMed Web of Science ®Google Scholar
• Zhao B, Quan H, Ma T, et al. 4, 4’-Diisothiocyanostilbene-2, 2’-disulfonic Acid (DIDS) ameliorates ischemia-hypoxia-induced white matter damage in neonatal rats through inhibition of the voltage-gated chloride channel ClC-2. Int J Mol Sci. 2015;16(12):10457–10469. DOI:https://doi.org/10.3390/ijms160510457.
   PubMedGoogle Scholar
• Peng X, Song J, Li B, et al. Umbilical cord blood stem cell therapy in premature brain injury: opportunities and challenges. J Neurosci Res. 2020;98(5):815–825. DOI:https://doi.org/10.1002/jnr.24548.
   PubMed Web of Science ®Google Scholar
• Song C-G, Zhang Y-Z, H-n W, et al. Stem cells: a promising candidate to treat neurological disorders. Neural Regen Res. 2018;13(7):1294–1304. DOI:https://doi.org/10.4103/1673-5374.235085.
   PubMed Web of Science ®Google Scholar
• Bagheri-Mohammadi S. Stem cell-based therapy as a promising approach in Alzheimer’s disease: current perspectives on novel treatment. Cell Tissue Bank. 2021;22(3):339–353.
   PubMed Web of Science ®Google Scholar
• Z-Y L, Li Y, Liu J. Progress in clinical trials of stem cell therapy for cerebral palsy. Neural Regen Res. 2021;16(7):1377–1382.
   PubMed Web of Science ®Google Scholar
• Ahn SY, Chang YS, Sung SI, et al. Mesenchymal stem cells for severe intraventricular hemorrhage in preterm infants: phase i dose-escalation clinical trial. Stem Cells Transl Med. 2018;7(12):847–856. DOI:https://doi.org/10.1002/sctm.17-0219.
   PubMed Web of Science ®Google Scholar
• Powell SB, Silvestri JM. Safety of intratracheal administration of human umbilical cord blood derived mesenchymal stromal cells in extremely low birth weight preterm infants. J Pediatr. 2019;210:209–213.e2.
   PubMed Web of Science ®Google Scholar
• Cotten CM, Murtha AP, Goldberg RN, et al. Feasibility of autologous cord blood cells for infants with hypoxic-ischemic encephalopathy. J Pediatr. 2014;164(5):973–979.e1. DOI:https://doi.org/10.1016/j.jpeds.2013.11.036.
   PubMed Web of Science ®Google Scholar
• Tsuji M, Sawada M, Watabe S, et al. Autologous cord blood cell therapy for neonatal hypoxic-ischaemic encephalopathy: a pilot study for feasibility and safety. Sci Rep. 2020;10(1):4603. DOI:https://doi.org/10.1038/s41598-020-61311-9.
   PubMed Web of Science ®Google Scholar
• Ahn SY, Chang YS, Kim JH, et al. Two-year follow-up outcomes of premature infants enrolled in the phase i trial of mesenchymal stem cells transplantation for bronchopulmonary dysplasia. J Pediatr. 2017;185:49–54.e2.
   PubMed Web of Science ®Google Scholar
• Yang J, Ren Z, Zhang C, et al. Safety of autologous cord blood cells for preterms: a descriptive study. Stem Cells Int. 2018;2018:5268057.
   PubMed Web of Science ®Google Scholar
• Phinney DG, Pittenger MF. Concise review: msc-derived exosomes for cell-free therapy. Stem Cells. 2017;35(4):851–858.
   PubMed Web of Science ®Google Scholar
• Razak A, Hussain A. Erythropoietin in perinatal hypoxic-ischemic encephalopathy: a systematic review and meta-analysis. J Perinat Med. 2019;47(4):478–489.
   PubMed Web of Science ®Google Scholar
• Juul SE, Comstock BA, Wadhawan R, et al. A randomized trial of erythropoietin for neuroprotection in preterm infants. N Engl J Med. 2020;382(3):233–243. DOI:https://doi.org/10.1056/NEJMoa1907423.
   PubMed Web of Science ®Google Scholar
• Juul SE, Pet GC. Erythropoietin and neonatal neuroprotection. Clin Perinatol. 2015;42(3):469–481.
   PubMed Web of Science ®Google Scholar
• Fischer HS, Reibel NJ, and Bührer C, et al. Prophylactic early erythropoietin for neuroprotection in preterm infants: a meta-analysis. Pediatrics. 2017;139(5) ;e20164317. doi:https://doi.org/10.1542/peds.2016-4317.
   PubMed Web of Science ®Google Scholar
• Ohlsson A, and Aher SM. Early erythropoiesis-stimulating agents in preterm or low birth weight infants. Cochrane Database Syst Rev. 2020;2(2):CD004863. doi:https://doi.org/10.1002/14651858. CD004863
   PubMedGoogle Scholar
• Lee JG, Woo YS, Park SW, et al. The neuroprotective effects of melatonin: possible role in the pathophysiology of neuropsychiatric disease. Brain Sci. 2019;9(10):285. DOI:https://doi.org/10.3390/brainsci9100285.
   PubMed Web of Science ®Google Scholar
• Merchant NM, Azzopardi DV, Hawwa AF, et al. Pharmacokinetics of melatonin in preterm infants. Br J Clin Pharmacol. 2013;76(5):725–733. DOI:https://doi.org/10.1111/bcp.12092.
   PubMed Web of Science ®Google Scholar
• Carloni S, Proietti F, and Rocchi M, et al. Melatonin pharmacokinetics following oral administration in preterm neonates. Molecules. 2017;22(12):2115. doi:https://doi.org/10.3390/molecules22122115.
   PubMed Web of Science ®Google Scholar
• Ahmed J, AK PS, Robertson NJ, et al. Melatonin for neuroprotection in neonatal encephalopathy: a systematic review & meta-analysis of clinical trials. Eur J Paediatr Neurol. 2021;31:38–45.
   PubMed Web of Science ®Google Scholar
• Sagrillo-Fagundes L, Assunção Salustiano EM, Yen PW, et al. Melatonin in pregnancy: effects on brain development and CNS programming disorders. Curr Pharm Des. 2016;22(8):978–986. DOI:https://doi.org/10.2174/1381612822666151214104624.
   PubMed Web of Science ®Google Scholar
• Jin Y, Choi J, Won J, et al. The relationship between autism spectrum disorder and melatonin during fetal development. Molecules. 2018 Jan 18;23(1):198.
   PubMed Web of Science ®Google Scholar
• Merchant N, Azzopardi D, Counsell S, et al. O-057 Melatonin as a novel neuroprotectant in preterm infants – a double blinded randomised controlled trial (mint study). Arch Dis Child. 2014;99(Suppl 2):A43. DOI:https://doi.org/10.1136/archdischild-2014-307384.125.
   Google Scholar
• Garofoli F, Longo S, Pisoni C, et al. Oral melatonin as a new tool for neuroprotection in preterm newborns: study protocol for a randomized controlled trial. Trials. 2021;22(1):82. DOI:https://doi.org/10.1186/s13063-021-05034-w.
   PubMedGoogle Scholar
• Lampl Y, Boaz M, Gilad R, et al. Minocycline treatment in acute stroke: an open-label, evaluator-blinded study. Neurology. 2007;69(14):1404–1410. DOI:https://doi.org/10.1212/01.wnl.0000277487.04281.db.
   PubMed Web of Science ®Google Scholar
• Zabad RK, Metz LM, Todoruk TR, et al. The clinical response to minocycline in multiple sclerosis is accompanied by beneficial immune changes: a pilot study. Mult Scler. 2007;13(4):517–526. DOI:https://doi.org/10.1177/1352458506070319.
   PubMedGoogle Scholar
• Buller KM, Carty ML, Reinebrant HE, et al. Minocycline: a neuroprotective agent for hypoxic-ischemic brain injury in the neonate? J Neurosci Res. 2009;87(3):599–608.
   PubMed Web of Science ®Google Scholar
• Hellstrom A, Ley D, Hallberg B, et al. IGF-1 as a drug for preterm infants: a step-wise clinical development. Curr Pharm Des. 2017;23(38):5964–5970. DOI:https://doi.org/10.2174/1381612823666171002114545.
   PubMed Web of Science ®Google Scholar
• Ley D, Hansen-Pupp I, Niklasson A, et al. Longitudinal infusion of a complex of insulin-like growth factor-I and IGF-binding protein-3 in five preterm infants: pharmacokinetics and short-term safety. Pediatr Res. 2013;73(1):68–74. DOI:https://doi.org/10.1038/pr.2012.146.
   PubMed Web of Science ®Google Scholar
• Coursodon CF, Dvorak B. Epidermal growth factor and necrotizing enterocolitis. Curr Opin Pediatr. 2012;24(2):160–164.
   PubMed Web of Science ®Google Scholar
• Aguirre A, Dupree JL, Mangin JM, et al. A functional role for EGFR signaling in myelination and remyelination. Nat Neurosci. 2007;10(8):990–1002. DOI:https://doi.org/10.1038/nn1938.
   PubMed Web of Science ®Google Scholar
• Guo K, Yang Y, Qiu J, et al. The expression profile of microRNAs in wistar rats with lipopolysaccharide-induced periventricular leukomalacia. J Mol Neurosci. 2013;51(3):941–949. DOI:https://doi.org/10.1007/s12031-013-9958-y.
   PubMed Web of Science ®Google Scholar
• Yang Y, Pan JJ, Feng Y, et al. Bioinformatics analyses combined microarray identify the differentially expressed microRNAs in periventricular leukomalacia. Neuro Endocrinol Lett. 2015 Dec;36(6):601–628.
   PubMed Web of Science ®Google Scholar
• Clinicaltrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000 Feb 29 Identifier NCT02076373, erythropoietin for the repair of cerebral injury in very preterm infants (epoRepair). 2014 Mar 3 [cited 2021 Jan 3];[about 4 screens]. Available from: https://www.clinicaltrials.gov/ct2/show/NCT02076373.
   Google Scholar
• Clinicaltrials.gov. Internet]. Bethesda (MD): National Library of Medicine (US). 2000 Feb 29 - .Identifier NCT02550054, Erythropoietin in premature infants to prevent encephalopathy. 2015 Sep 15 [cited 2021 Jan 3];[about 4 screens]. Available from: https://www.clinicaltrials.gov/ct2/show/NCT02550054
   Google Scholar
• Clinicaltrials.gov. [Internet]. Bethesda (MD): National Library of Medicine (US). 2000Feb 29 Identifier NCT02745990, recombinant human erythropoietin improve neurodevelopmental outcomes in extremely preterm infants (EPO). 2016 Apr 21 [cited 2021 Jan 3] about 4 screens Available from: https://www.clinicaltrials.gov/ct2/show/NCT02745990.
   Google Scholar
• Clinicaltrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000Feb 29 Identifier NCT03169881, darbepoetin trial to improve red cell mass and neuroprotection in preterm infants (Darbe). 2017 May 30 [cited 2021 Jan 3] about 4 screens Available from: https://www.clinicaltrials.gov/ct2/show/NCT03169881.
   Google Scholar
• Clinicaltrials.gov. Internet]. Bethesda (MD): National Library of Medicine (US). 2000Feb 29 Identifier NCT04235673, Oral melatonin as neuroprotectant in preterm infants. 2020 Jan 22[cited 2021 Jan 3] [about 4 screens]. Available from: https://www.clinicaltrials.gov/ct2/show/NCT04235673
   Google Scholar
• Clinicaltrials.gov. Internet]. Bethesda (MD): National Library of Medicine (US). 2000Feb 29 Identifier NCT00515281, Inhaled nitric oxide and neuroprotection in premature infants (NOVA2). 2007 Aug 13 [cited 2021 Jan 3];[about 4 screens]. Available from. https://www.clinicaltrials.gov/ct2/show/NCT04235281
   Google Scholar
• Benders MJ, Kersbergen KJ, de Vries LS. Neuroimaging of white matter injury, intraventricular and cerebellar hemorrhage. Clin Perinatol. 2014 Mar;41(1):69–82.
   PubMed Web of Science ®Google Scholar
• Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research, Stoll BJ, Hansen NI, Bell EF, et al. Network. trends in care practices, morbidity, and mortality of extremely preterm neonates, 1993-2012. JAMA. 2015;314(10):1039–1051.
   PubMed Web of Science ®Google Scholar